Filing Details

Accession Number:
0001562180-24-006885
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-09-20 16:00:59
Reporting Period:
2024-09-18
Accepted Time:
2024-09-20 16:00:59
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1822462 Foghorn Therapeutics Inc. FHTX Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1939167 Carlos Costa 500 Technology Square
Ste #700
Cambridge MA 02139
Chief People Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-09-18 11,574 $3.72 11,574 No 4 M Direct
Common Stock Disposition 2024-09-18 11,574 $10.05 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2024-09-18 11,574 $0.00 11,574 $3.72
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
76,402 2029-02-12 No 4 M Direct
Footnotes
  1. The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 11, 2024.
  2. The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $10.00 to $10.25 per share.
  3. The option vested as to 25% of the underlying shares of common stock on August 29, 2019, and at a rate of 6.25% of the underlying shares thereafter on the first day of each calendar quarter following such first anniversary until the option was fully vested.